HR 405 United States House · 118th Congress

Essential Medicines Strategic Stockpile Act of 2023

Summary
Essential Medicines Strategic Stockpile Act of 2023 This bill requires the Department of Health and Human Services (HHS) to create a pilot program to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. To carry out the pilot program, HHS must enter into contracts for a term of up to three years with drug manufacturers, co-op or chain pharmacy warehouses, or other eligible entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2023
Committee Review
Floor Vote
President
Introduced Jan 20, 2023 Last action Jan 27, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Jan 27, 2023
Committee
Referred to the Subcommittee on Health.
lower
Jan 20, 2023
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jan 20, 2023
Introduced
Introduced in House
lower
1 primary · 3 co-sponsors

Sponsors